Jane Street Group, LLC Innoviva, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 136,361 shares of INVA stock, worth $2.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,361

Previous 93,143 46.4%

Holding current value

$2.51 Million

Previous $1.53 Million 72.3%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$16.33 - $20.04 $705,749 - $866,088	43,218 Added 46.4%	136,361 $2.63 Million
Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $1.14 Million - $1.3 Million	-79,070 Reduced 45.91%	93,143 $1.53 Million
Q1 2024 May 15, 2024	BUY	$14.56 - $16.78 $2.29 Million - $2.64 Million	157,344 Added 1058.2%	172,213 $2.62 Million
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $958,348 - $1.27 Million	-77,788 Reduced 83.95%	14,869 $238,000
Q3 2023 Nov 14, 2023	BUY	$12.37 - $13.89 $163,234 - $183,292	13,196 Added 16.61%	92,657 $1.2 Million
Q2 2023 Aug 14, 2023	BUY	$11.39 - $13.72 $454,893 - $547,949	39,938 Added 101.05%	79,461 $1.01 Million
Q1 2023 May 15, 2023	BUY	$10.73 - $13.6 $83,157 - $105,400	7,750 Added 24.39%	39,523 $444,000
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $374,921 - $437,831	31,773 New	31,773 $420,000
Q2 2022 Aug 16, 2022	SELL	$14.32 - $19.88 $212,609 - $295,158	-14,847 Reduced 31.35%	32,507 $480,000
Q1 2022 May 17, 2022	BUY	$15.39 - $20.25 $538,280 - $708,264	34,976 Added 282.57%	47,354 $916,000
Q4 2021 Feb 15, 2022	SELL	$15.91 - $18.72 $44,945 - $52,884	-2,825 Reduced 18.58%	12,378 $213,000
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $2,873 - $3,503	251 Added 1.68%	15,203 $204,000
Q1 2021 May 18, 2021	BUY	$11.06 - $12.87 $29,286 - $34,079	2,648 Added 21.52%	14,952 $179,000
Q4 2020 Feb 17, 2021	SELL	$9.33 - $12.48 $24,351 - $32,572	-2,610 Reduced 17.5%	12,304 $152,000
Q3 2020 Nov 17, 2020	BUY	$10.33 - $14.49 $154,061 - $216,103	14,914 New	14,914 $156,000
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $184,899 - $347,228	-22,799 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $1.87 Million - $2.61 Million	-181,527 Reduced 88.84%	22,799 $323,000
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $2.05 Million - $2.97 Million	204,326 New	204,326 $2.15 Million
Q2 2019 Aug 15, 2019	SELL	$13.1 - $14.95 $248,860 - $284,005	-18,997 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$13.69 - $20.06 $260,068 - $381,079	18,997 New	18,997 $267,000
Q4 2018 Feb 15, 2019	SELL	$13.96 - $18.26 $459,591 - $601,155	-32,922 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $303,894 - $350,047	22,296 Added 209.82%	32,922 $502,000
Q2 2018 Aug 15, 2018	BUY	$13.44 - $17.59 $142,813 - $186,911	10,626 New	10,626 $147,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.99 $562,888 - $693,005	-40,789 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$11.73 - $14.75 $359,160 - $451,630	30,619 Added 301.07%	40,789 $579,000
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $122,650 - $143,600	10,170	10,170 $144,000

Others Institutions Holding INVA

# of Institutions

232

Shares Held

79.1M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.28B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Innoviva, Inc. Transaction History